Kiniksa Pharmaceuticals Stock Price Prediction
| KNSA Stock | USD 21.09 0.12 0.57% |
Oversold Vs Overbought
39
Oversold | Overbought |
Quarterly Earnings Growth 5.5 | EPS Estimate Next Quarter 0.07 | EPS Estimate Current Year (0.21) | EPS Estimate Next Year 0.6833 | Wall Street Target Price 36 |
Using Kiniksa Pharmaceuticals hype-based prediction, you can estimate the value of Kiniksa Pharmaceuticals from the perspective of Kiniksa Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Kiniksa Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Kiniksa because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Kiniksa Pharmaceuticals after-hype prediction price | USD 20.98 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Kiniksa |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kiniksa Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Kiniksa Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Kiniksa Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kiniksa Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Kiniksa Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Kiniksa Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Kiniksa Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kiniksa Pharmaceuticals' historical news coverage. Kiniksa Pharmaceuticals' after-hype downside and upside margins for the prediction period are 18.07 and 23.89, respectively. We have considered Kiniksa Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Kiniksa Pharmaceuticals is not too volatile at this time. Analysis and calculation of next after-hype price of Kiniksa Pharmaceuticals is based on 3 months time horizon.
Kiniksa Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Kiniksa Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kiniksa Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kiniksa Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.37 | 2.91 | 0.11 | 0.09 | 9 Events / Month | 16 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
21.09 | 20.98 | 0.52 |
|
Kiniksa Pharmaceuticals Hype Timeline
Kiniksa Pharmaceuticals is now traded for 21.09. The entity has historical hype elasticity of -0.11, and average elasticity to hype of competition of 0.09. Kiniksa is projected to decline in value after the next headline, with the price expected to drop to 20.98. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.52%, whereas the daily expected return is now at -0.37%. The volatility of related hype on Kiniksa Pharmaceuticals is about 1210.21%, with the expected price after the next announcement by competition of 21.18. About 98.0% of the company shares are owned by institutional investors. The book value of Kiniksa Pharmaceuticals was now reported as 6.06. The company has Price/Earnings To Growth (PEG) ratio of 0.25. Kiniksa Pharmaceuticals recorded a loss per share of 0.12. The entity had not issued any dividends in recent years. The firm had 1:1 split on the 28th of June 2024. Given the investment horizon of 90 days the next projected press release will be in about 9 days. Check out Kiniksa Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Kiniksa Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Kiniksa Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Kiniksa Pharmaceuticals' future price movements. Getting to know how Kiniksa Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kiniksa Pharmaceuticals may potentially react to the hype associated with one of its peers.
Kiniksa Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Kiniksa price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kiniksa using various technical indicators. When you analyze Kiniksa charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Kiniksa Pharmaceuticals Predictive Indicators
The successful prediction of Kiniksa Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Kiniksa Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Kiniksa Pharmaceuticals based on analysis of Kiniksa Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Kiniksa Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kiniksa Pharmaceuticals's related companies. | 2022 | 2023 | 2024 (projected) | Payables Turnover | 5.95 | 6.85 | 7.2 | Days Of Inventory On Hand | 167.86 | 200.97 | 137.66 |
Story Coverage note for Kiniksa Pharmaceuticals
The number of cover stories for Kiniksa Pharmaceuticals depends on current market conditions and Kiniksa Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kiniksa Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kiniksa Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Kiniksa Pharmaceuticals Short Properties
Kiniksa Pharmaceuticals' future price predictability will typically decrease when Kiniksa Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kiniksa Pharmaceuticals often depends not only on the future outlook of the potential Kiniksa Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kiniksa Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 71.9 M | |
| Cash And Short Term Investments | 206.4 M |
Complementary Tools for Kiniksa Stock analysis
When running Kiniksa Pharmaceuticals' price analysis, check to measure Kiniksa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiniksa Pharmaceuticals is operating at the current time. Most of Kiniksa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiniksa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiniksa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiniksa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world |